Who We Are
At Vaniam Group, we believe in the power of connection—connection that drives innovation, inspires progress, and improves lives. Since 2007, we’ve partnered with biopharma innovators, researchers, physicians, and patients to tackle some of today’s biggest healthcare challenges. Your breakthroughs inspire us, and our work is focused on amplifying your impact to reach the people who need it most.
The Vaniam Difference defines who we are. Through unparalleled connectivity, we build bridges across the healthcare ecosystem—linking community physicians with researchers, emerging data with actionable insights, and your vision with patients. With strategic intelligence, we turn complex challenges into actionable strategies, equipping you with the insights and confidence to make meaningful decisions.
We are proud to operate as a fully virtual and dynamic team, bringing together diverse perspectives and talents from across the globe. By embracing differences and championing inclusion, we foster creativity and collaboration to develop solutions that resonate for all. At the same time, our commitment to sustainability drives us to work in ways that minimize our environmental impact, helping us protect the planet while delivering powerful results for our clients.
At Vaniam Group, we’re more than partners—we’re collaborators who care deeply about your success. Together, we help you tell your story in clear, impactful ways that inspire action. Because when great science meets great communication, it has the power to truly transform lives—and that’s what motivates us every day.
Vaniam Group is a woman-owned business enterprise certified by the Women’s Business Enterprise National Council (WBENC).
Our Network of Agencies
Commercial Strategy
and Planning
Insights Gathering
Accredited Education
Research Support
Leadership
Deanna B. van Gestel, Founder & CEO
Deanna B. van Gestel founded Vaniam Group in 2007 with a vision to connect people, ideas, and science in new and meaningful ways. As a trailblazer in healthcare communications, she redefined how teams collaborate by establishing a 100% virtual-by-design model—long before it became the norm. This innovative approach has fostered an environment of flexibility, inclusivity, and excellence, setting a new standard for how meaningful work gets done.
A people-first leader, Deanna is passionate about building an organization that empowers biopharma innovators and employees alike to reach their full potential. Her focus extends beyond advancing cutting-edge medical science—across oncology, rare diseases, metabolic disorders, immunology, and more—to reimagining how work can inspire, engage, and drive meaningful impact in the healthcare field.
Deanna’s dedication to connection and innovation reaches far beyond Vaniam Group. She serves as a board member for Conquer Cancer®, the ASCO Foundation, and as a member of its executive committee, working to accelerate progress in cancer research. She is also part of the Tugboat Institute, a community of purpose-driven business leaders, reflecting her commitment to transformative ideas that leave a legacy.
Under Deanna’s leadership, Vaniam Group thrives as a purpose-driven, high-science organization shaping the future of medical communications—and the workplace. By fostering collaboration across the healthcare ecosystem, she continues to inspire innovation, amplify the impact of groundbreaking therapies, and champion a workplace culture rooted in inclusion and connection.
Giving
Founded in 2014 by Vaniam Group CEO Deanna van Gestel, Women Leaders in Oncology (WLO) recognizes and empowers women who have dedicated their careers to advancing oncology research. WLO amplifies female voices and nurtures connections among women leaders through networking, mentoring, and philanthropy. Every year, WLO raises funds for the WLO Women Who Conquer Cancer Young Investigator Award, which is awarded to young female oncologists in recognition of their promising research. In addition to the 9 awards already provided, WLO is actively fundraising toward a 5-year target endowment of $1.35 million, which will be used to fund future awards.
Encouraging promising Black oncologists
In addition to recognizing rising female leaders within the industry, Vaniam Group is honored to fund the Conquer Cancer-Vaniam Group LLC Young Investigator Award for promising young Black oncologists. Vaniam Group has provided 2 of these grants since the award’s inception.
